
zzso zzso is a zzso agent commonly used for various zzso and zzso disorders, including chronic zzso leukemia and zzso cell zzso We show here that zzso low-level treatment with zzso zzso a variety of defects in zzso replication and zzso zzso treatment zzso decreased the rate of zzso DNA synthesis and altered the cell cycle timing of zzso zzso zzso reduced the expression levels of zzso repeat zzso zzso In some cells, zzso caused a rapid loss of zzso restriction zzso zzso zzso zzso zzso zzso indicated that zzso repeat binding factors zzso and zzso zzso from zzso DNA after zzso zzso zzso protein zzso from zzso treated cells showed a modest reduction in DNA binding activity and a change in zzso point as measured by zzso gel zzso However, chronic low level zzso treatment did not evoke a DNA replication checkpoint response, suggesting that the mechanism of action is distinct from the zzso zzso checkpoint zzso We conclude that therapeutic doses of zzso zzso effects zzso replication and zzso through a mechanism that may involve the direct modification of zzso These findings provide new insight into the potential mechanisms of action of zzso at zzso and in cancer zzso 

